πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 166 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8541182

Biological marker for inflammation

CAN-FITE BIOPHARMA LTD. Β· Granted Tue Sep 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8529872

Seeds and markers for use in imaging

The Board of Regents of the University of Texas System Β· Granted Tue Sep 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8436224

Methods for testing for caloric restriction (CR) mimetics

BioMarker Pharmaceuticals, Inc. Β· Granted Tue May 07 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8403844

Methods for interventions

BioMarker Pharmaceuticals, Inc. Β· Granted Tue Mar 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8241862

Perinucleolar compartment as a cancer marker

Northwestern University Β· Granted Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8198254

Annexin A9 (ANXA9) biomarker and therapeutic target in epithelial cancer

The Regents of the University of California Β· Granted Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8183009

Assaying cellular markers for the evaluation of tumors

Precision Therapeutics, Inc. Β· Granted Tue May 22 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8173602

Detecting CYP24 expression level as a marker for predisposition to cancer

The Regents of the University of California Β· Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8163509

Biological markers predictive of anti-cancer response to insulin-like growth factor-1 rece

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8076099

Biomarkers of Francisella infection

The Board of Regents of the University of Texas System Β· Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8030010

Method for detecting a biomarker of oxidative stress in a biological sample

INSTITUT DE CARDIOLOGIE DE MONTREAL Β· Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8030012

Id-1 and Id-2 genes and products as markers of epithelial cancer

The Regents of the University of California Β· Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7981610

ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphom

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7960605

Methods for testing for caloric restriction (CR) mimetics

BioMarker Pharmaceuticals, Inc. Β· Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7955602

Annexin proteins and autoantibodies as serum markers for cancer

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Jun 07 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7897340

Use of tumor susceptibilty gene 101 (TSG 101) as a prognostic and diagnostic marker

The Board of Regents of the University of Texas System Β· Granted Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7879548

Detection of biomarkers for neuropsychiatric disorders

The Regents of the University of California Β· Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7825159

Mixtures of aromatic esters for marking or tagging organic products, marker compositions c

UNITED COLOR MANUFACTURING, INC. Β· Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7807393

Biomarkers for prostate cancer

Northwestern University Β· Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7776593

Hes6 as a marker of pancreatic endocrine cells

The Regents of the University of California Β· Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7759081

Annexin proteins and autoantibodies as serum markers for cancer

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Jul 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7670599

YKL-40 as a marker and prognostic indicator for cancers

The Regents of the University of California Β· Granted Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7648826

Detecting CYP24 expression level as a marker for predisposition to cancer

The Regents of the University of California Β· Granted Tue Jan 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7442558

Phthalamide-lanthanide complexes for use as luminescent markers

The Regents of the University of California Β· Granted Tue Oct 28 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted